Results 241 to 250 of about 574,105 (363)

Associations between root-inhabiting fungi and 40 species of medicinal plants with potential applications in the pharmaceutical and biotechnological industries

, 2019
Piotr Piszczek, Karolina Kuszewska, Janusz Błaszkowski, Anna Sochacka-Obruśnik, Anna Stojakowska, Szymon Zubek   +5 more
openalex   +2 more sources

Different routes the same destination: a comparative study of antitrust regulation for pharmaceutical industry in the United States and China. [PDF]

Front Pharmacol
Weng J, Liu N.
europepmc   +1 more source

Myeloperoxidase Luminol Reaction – A Novel Faecal Assay for Predicting Colonoscopy Findings in Patients with Ulcerative Colitis: A Pilot Cross‐Sectional Clinical Study

Advanced Healthcare Materials, EarlyView.
Can luminol detect faecal inflammation? This study explores the development and optimisation of a rapid novel assay ‐ Myeloperoxidase Luminol Reaction (MPOLR) for the detection of faecal myeloperoxidase activity. This simple and rapid luminol‐based approach competes with clinically validated faecal biomarkers in predicting endoscopic findings in ...
Viraj Kariyawasam, Taylor Davis, Mark Ghali, David Tejcek, Thomas R O'Neil, Ella Verley, Matthew Griffiths, Miguel Campos, Ingrid Bonney, Andrew C. Bulmer, Yogambha Ramaswamy, Nikola Mitrev, Crispin Corte, Paul K. Witting, Belal Chami   +14 more
wiley   +1 more source

Blockchain Applications in the Pharmaceutical Industry. [PDF]

Blockchain Healthc Today
Gaynor M, Gillespie K, Roe A, Crannage E, Tuttle-Newhall JE.   +4 more
europepmc   +1 more source

Bioprinting Organs—Science or Fiction?—A Review From Students to Students

Advanced Healthcare Materials, EarlyView.
Bioprinting artificial organs has the potential to revolutionize the medical field. This is a comprehensive review of the bioprinting workflow delving into the latest advancements in bioinks, materials and bioprinting techniques, exploring the critical stages of tissue maturation and functionality.
Nicoletta Murenu, Camilla Mussoni, Mateo S. Andrade Mier, Paula Buettner, Nathaly Chicaiza‐Cabezas, Yi‐Yu Robin Dai, Jessica Faber, Maren Fiedler, Zan Lamberger, Xuen Jen Ng, Vanessa Moessler, Anna Rederer, Jonas Roeder, Sabrina Stecher, Katinka Theis, Jeanette Weigelt, Silvia Budday, Gregor Lang, Natascha Schaefer   +18 more
wiley   +1 more source

An Assessment of Structural (Organizational) Capital Indicators in Knowledge Intensive Industries Evidence from Pharmaceutical Industry [PDF]

, 2012
Gholamhossein Mehralian, Hamid Reza Rasekh, Peyman Akhavan, Gholamhossein Farzandi   +3 more
openalex  

Manufacturing capability networks: A case study on production allocation decision in the pharmaceutical industry

, 2009
Kah‐Hin Chai, C-M Yap, M Pellerin
openalex   +2 more sources

The role of budget impact in reimbursement decisions in The Netherlands: interviews with decision-makers and pharmaceutical industry representatives. [PDF]

Eur J Health Econ
Reckers-Droog V, Enzing J, Brouwer W.
europepmc   +1 more source

Extracellular‐Matrix‐Based Materials from Decellularized Tissue: Opportunities, Challenges, and Future Directions in Regenerative Medicine

Advanced Healthcare Materials, EarlyView.
Extracellular matrix‐based materials derived from decellularized tissue (dECM) harness the tissue's native bioactivity to guide repair and regeneration across diverse clinical applications. This perspective highlights clinical uses of dECM biomaterials and advances in fabrication methods such as electrospinning and 3D printing.
Madeline Laude, Vasiliki Kolliopoulos, Antonios G. Mikos, Lisa J. White, Elizabeth Cosgriff‐Hernandez   +4 more
wiley   +1 more source

Impact of Employee’s Behavior and Culture on Organizations Productivity in Pharmaceutical Industries of Bangaluru

, 2011
Arun Babu Angadi, D. Murahari Naik
openalex   +1 more source